Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005523/en/
Drs. Kevin Tracey, Valentin Pavlov, Sangeeta Chavan welcome participants to the 2020 Bioelectronic Medicine Summit (Credit: Feinstein Institutes)
Bioelectronic medicine combines molecular medicine, neuroscience, and biomedical engineering to develop innovative therapies to treat a variety of diseases and conditions through targeted stimulation of nerves, including paralysis, arthritis, pulmonary hypertension, and inflammatory bowel disease. Due to coronavirus disease 2019 (COVID-19), this year’s summit was held virtually and drew nearly 200 attendees, including esteemed academic leaders, members of the media, and industry professionals.
“Even though our recent focus has been on discovering a COVID-19 treatment, we continue